1. Home
  2. SLGL vs ANIK Comparison

SLGL vs ANIK Comparison

Compare SLGL & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$49.36

Market Cap

117.8M

Sector

Health Care

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

N/A

Current Price

$9.81

Market Cap

134.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLGL
ANIK
Founded
1997
1983
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.8M
134.8M
IPO Year
2018
1993

Fundamental Metrics

Financial Performance
Metric
SLGL
ANIK
Price
$49.36
$9.81
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$50.00
$16.00
AVG Volume (30 Days)
19.6K
153.9K
Earning Date
11-20-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,970,000.00
$112,806,000.00
Revenue This Year
$121.82
N/A
Revenue Next Year
N/A
$4.79
P/E Ratio
N/A
N/A
Revenue Growth
62.04
30.55
52 Week Low
$4.02
$7.87
52 Week High
$54.54
$18.37

Technical Indicators

Market Signals
Indicator
SLGL
ANIK
Relative Strength Index (RSI) 72.77 55.14
Support Level $40.10 $9.31
Resistance Level $44.99 $9.85
Average True Range (ATR) 3.02 0.20
MACD 0.60 0.04
Stochastic Oscillator 91.68 79.63

Price Performance

Historical Comparison
SLGL
ANIK

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

Share on Social Networks: